Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center*

By D. Warren, Sunita J Shukla, M. Olsen, Marin Kollef, C. Hollenbeak, M. Cox, Max M. Cohen, Victoria J. Fraser. Critical Care Medicine, 2003

607 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Epidemiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/495534dbf904fd482939b449246161fb632c65a5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Critical Care and Intensive Care Medicine

1. Ayumi Shintani
2. Robert S. Dittus
3. E. W. Ely
4. Marin Kollef
5. Gordon R. Bernard
6. J. Chastre
7. Pratik Pandharipande

In Epidemiology

1. Ayumi Shintani
2. Robert S. Dittus
3. J. Chastre
4. Pratik Pandharipande

In Pulmonary and Respiratory Medicine

1. E. W. Ely
2. Marin Kollef
3. Ayumi Shintani
4. Robert S. Dittus
5. H. Collard

Citations in the corpus

• Clinical and economic consequences of ventilator-associated pneumonia: A systematic review (2005, background): “(7) found that VAP was associated with attributable costs of $11,897 (95% CI, $5,265–$26,214) in 2003 in a large suburban nonteaching hospital.”
• Costs associated with delirium in mechanically ventilated patients* (2004, background): “Some of the costs of critical care are due to complications such as ventilator-associated pneumonia (13, 14) and catheter-related bloodstream infection (15).”
• International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia (2017, background): “Worse outcomes have been consistently reported over the years (6,7,8), and mean hospital charges per VAP patient have increased by approximately 40,000 US$ (7,8) In a systematic review of economic analyses of health-care associated infections the mean attributable cost of VAP was 9969 $ ( 9).”